Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.18 -0.78 (-1.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Return on Invested Capital [ROIC] (2013 - 2026)

Updated

Ani Pharmaceuticals (ANIP) recorded Return on Invested Capital [ROIC] of 12.93% in Q2 2026, up 11.51 percentage points from 1.42% a year earlier and up 1.48 percentage points from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Return on Invested Capital [ROIC] (2013 - 2026) Analysis & Trends

For FY2025, Ani Pharmaceuticals reported Return on Invested Capital [ROIC] of 11.56%, up 11.49 percentage points from FY2024.

  • Annual Return on Invested Capital [ROIC] has a five-year change of +15.13 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Invested Capital [ROIC] came in at 0.07% in FY2024 (-6.66 pp), 6.73% in FY2023 (+11.15 pp), -4.42% in FY2022 (+1.62 pp) and -6.03% in FY2021 (-2.47 pp).
  • The Q2 2026 figure is the highest quarterly Return on Invested Capital [ROIC] in data going back to Q1 2013.
  • On a year-over-year basis, Return on Invested Capital [ROIC] has increased for four consecutive quarters, with an average year-over-year change of +2.35 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Invested Capital [ROIC] in the last five years was a gain of 13.80 percentage points in Q3 2023, against a drop of 6.44 percentage points in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at 11.45% (Q1 2026), 10.89% (Q4 2025) and 7.35% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 16.10%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 18.68%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 3.56%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 21.95%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 28.83%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 14.33%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 13.44%
10 Ani Pharmaceuticals 1.72 Bn 502.13 Mn 165.89 Mn 12.93%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.93%
Mar 31, 2026 11.45%
Dec 31, 2025 10.89%
Sep 30, 2025 7.35%
Jun 30, 2025 1.42%
Mar 31, 2025 0.68%
Dec 31, 2024 0.07%
Sep 30, 2024 1.51%
Jun 30, 2024 5.16%
Mar 31, 2024 6.51%
Dec 31, 2023 6.18%
Sep 30, 2023 5.96%
Jun 30, 2023 1.44%
Mar 31, 2023 -0.78%
Dec 31, 2022 -4.50%
Sep 30, 2022 -7.84%
Jun 30, 2022 -7.56%
Mar 31, 2022 -7.72%
Dec 31, 2021 -5.96%
Sep 30, 2021 -3.19%
API Access

Ani Pharmaceuticals Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=ANIP&period=max&api_key=YOUR_API_KEY